Table 2.
Overall adverse reactions and unsolicited adverse reactions within 28 or 30 days after whole vaccination procedure in inactivated vaccine group vs. control group.
| No. of studies | RR (95% CI) | I2 | P -value | |
|---|---|---|---|---|
| Overall adverse reactions within 28 or 30 days after whole vaccination procedure | 2 | 1.59 [1.26, 2.01] | 77 | <0.05* |
| Unsolicited adverse reactions within 28 or 30 days after whole vaccination procedure | ||||
| Overall | 4 | 1.21 [1.07, 1.36] | 14 | <0.05* |
| Related to study vaccination | 3 | 1.96 [1.59, 2.41] | 20 | <0.05* |
| Severe | 3 | 2.35 [0.78, 7.03] | 0 | >0.05 |
| Life-threatening | 3 | 1.00 [0.06, 15.94] | Not applicable | >0.05 |
| Serious | 3 | 1.63 [0.45, 5.88] | 0 | >0.05 |
| Medically-attended | 1 | 0.96 [0.74, 1.25] | Not applicable | >0.05 |
| Leading to discontinuation | 3 | 2.99 [0.36, 24.93] | 0 | >0.05 |
*
P < 0.05.